Literature DB >> 29465806

Principles of haemophilia care: The Asia-Pacific perspective.

S Dunkley1, J C M Lam2, M J John3, R S M Wong4, H Tran5, R Yang6, S C Nair7, M Shima8, A Street9, A Srivastava10.   

Abstract

Optimal haemophilia care is best established and implemented through a well-coordinated plan guided by clearly defined principles and priorities. A document which enunciates those details is therefore important. A successful example of this approach is the definition of principles of haemophilia care (PHC) outlined by the European Association for Haemophilia and Associated Disorders (EAHAD) and also the World Federation of Hemophilia. A similar document applicable to the Asia-Pacific region must take into account not only the highly varied healthcare systems but also the tremendous socio-economic and cultural diversities which impact provision of such care. The Asia-Pacific Haemophilia Working Group (APHWG), representing the countries in this region, has prepared this perspective of the PHC. While endorsing the overall framework outlined by EAHAD, this APHWG document emphasizes regional priorities on education and training of healthcare personnel in the diagnosis and management of hereditary bleeding disorders. Central coordinating agencies with wide stakeholder input, networks of haemophilia treatment centres and national registries as well as robust processes for procurement and distribution of safe and effective clotting factor concentrates (CFCs), implementation of prophylaxis programmes and management of patients with inhibitors should also be developed. The implementation of these strategies should lead to establishment of good comprehensive care programmes. This document should also be an advocacy tool to lobby for improved care for people with haemophilia (PWH) in the region. We urge national healthcare policy makers to consider these principles and initiate strong and decisive action to reach these goals.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Asia-Pacific; comprehensive care; haemophilia; management; principles; treatment

Mesh:

Substances:

Year:  2018        PMID: 29465806     DOI: 10.1111/hae.13425

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  6 in total

1.  Principles of care for acquired hemophilia.

Authors:  Gerry Dolan; Gary Benson; Annette Bowyer; Hermann Eichler; Cedric Hermans; Victor Jiménez-Yuste; Rolf Ljung; Debra Pollard; Elena Santagostino; Silva Zupančić Šalek
Journal:  Eur J Haematol       Date:  2021-03-18       Impact factor: 2.997

2.  Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial.

Authors:  Renchi Yang; Jing Sun; Yongqiang Zhao; Xuefeng Wang; Depei Wu; Despina Tseneklidou-Stoeter; Junde Wu; Nikki Church
Journal:  Haemophilia       Date:  2019-04-17       Impact factor: 4.287

3.  Analysis of nationwide hemophilia care: A cohort study using two Japanese healthcare claims databases.

Authors:  Ei Kinai; Midori Ono; Akinori Oh; Mihoko Ota; Yasuo Myaguchi; Hitoshi Ueda
Journal:  Health Sci Rep       Date:  2022-01-27

4.  Changing paradigms of hemophilia care across larger specialized treatment centers in the European region.

Authors:  Jerzy Windyga; Ana Boban; Irena Zupan; Niamh O'Connell; Cedric Hermans
Journal:  Ther Adv Hematol       Date:  2022-03-28

5.  Prophylactic emicizumab for hemophilia A in the Asia-Pacific region: A randomized study (HAVEN 5).

Authors:  Renchi Yang; Shujie Wang; Xuefeng Wang; Jing Sun; Ampaiwan Chuansumrit; Jianfeng Zhou; Christophe Schmitt; Wanling Hsu; Jeffrey Xu; Lindong Li; Tiffany Chang; Xielan Zhao
Journal:  Res Pract Thromb Haemost       Date:  2022-03-07

6.  A survey of characteristics and current educational needs of hemophilia treatment centers within Asia Pacific.

Authors:  Joyce C M Lam; M Joseph John; Alison Street
Journal:  Res Pract Thromb Haemost       Date:  2018-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.